Kwangdong Clarithromycin is commonly used for acute bacterial infections across several therapeutic domains. The medication is generally applied in clinical settings that involve acute or disruptive symptom patterns.

It is used in situations involving conditions such as community-acquired pneumonia, acute bronchitis exacerbations, pharyngitis, acute otitis media, and uncomplicated skin infections. Furthermore, it plays a role in combination regimens aimed at addressing Helicobacter pylori associated with duodenal ulcer disease and managing opportunistic mycobacterial infections.

It helps address symptom clusters that may become intense or disruptive, such as cough, ear pain, or localized swelling. It is often used as an alternative therapeutic option for patients who require an antibiotic but have a known hypersensitivity to penicillin drugs. This use helps maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Acute Symptoms
Primary Use Focus	Infections involving acute symptom patterns
Key Symptom Axes	Symptoms related to physical discomfort and systemic imbalance
Patient Benefit	Contributes to easing the overall symptom load

Regulatory References

1. DailyMed listing published by the National Library of Medicine (NIH)

Eligibility Map: Who Can and Cannot Use Kwangdong Clarithromycin

Official regulatory documents establish strict criteria for the use of Clarithromycin, defining populations who are eligible, restricted, or absolutely prohibited from taking the medicine.

Category	Official Regulatory Statement
Populations for whom use is allowed	Adults and adolescents 12 years and older. Children 6 months to 12 years are eligible, typically requiring the oral suspension formulation.
Populations for whom use is contraindicated	Patients with known macrolide hypersensitivity, a history of QT prolongation or ventricular arrhythmia, or uncorrected hypokalaemia/hypomagnesaemia. Contraindicated in severe hepatic failure combined with renal impairment.

Condition-Specific Eligibility Rules

Condition/Comorbidity	Eligibility Status (Regulatory Wording)
Severe Renal Impairment (CLcr < 30 mL/min)	Use requires caution; dosage reduction is necessary.
Pregnancy	Not recommended unless the benefit outweighs the potential risk, as safety has not been established.

---

Resulting Eligibility Structure

The medicine is strictly contraindicated for patients taking specific concomitant medications, including lovastatin, simvastatin, cisapride, pimozide, and ergot alkaloids. Safety and efficacy are not established in children younger than 6 months. These rules formally demarcate the populations for whom the drug is approved and those for whom it is prohibited or limited, based on cardiac, hepatic, and renal status.

Interactions with other medicines and products

Clarithromycin interacts with many other medicines primarily by inhibiting the enzyme CYP3A4, leading to increased levels of those co-administered medicines in the body. It also interacts by inhibiting P-glycoprotein and through additive pharmacodynamic effects, such as the potential to prolong the QT interval.

---

Contraindicated Combinations

Official regulatory documents strictly prohibit combining Clarithromycin with the following medicines due to the risk of serious adverse reactions:

• HMG-CoA Reductase Inhibitors (Statins): Lovastatin and Simvastatin, due to a significant risk of muscle toxicity (rhabdomyolysis).
• Ergot Alkaloids: Ergotamine and Dihydroergotamine, due to a risk of ergot toxicity characterized by vasospasm.
• Specific Antihistamines/Other Agents: Astemizole, Cisapride, Pimozide, and Terfenadine, due to the potential for fatal cardiac arrhythmias (QT prolongation).
• Other Agents: Ticagrelor, Ranolazine, Lomitapide, and Lurasidone.

---

Combinations Requiring Specific Management

Use of Clarithromycin with certain other medicines requires caution, monitoring, or specific administration rules:

• Antacids containing aluminum and/or magnesium may reduce the absorption of Clarithromycin, necessitating at least a 2-hour separation in dosing time.
• The combination with Colchicine is contraindicated in patients with kidney or liver impairment due to the risk of colchicine toxicity.
• Co-administration with Zidovudine requires taking the medicines at least 2 hours apart to prevent reduced Zidovudine levels.

Targeted Inhibition of Bacterial Protein Synthesis

Clarithromycin acts by binding to the 50 S ribosomal subunit inside susceptible bacteria, specifically targeting the 23 S ribosomal RNA. This interaction physically blocks the ribosomal tunnel, preventing the translocation of the growing polypeptide chain, which is essential for protein synthesis. The molecular blockade arrests the creation of bacterial proteins needed for replication, resulting in a bacteriostatic effect.

---

Biological Constraints on Mechanistic Function

The mechanism is constrained by bacterial resistance mechanisms that reduce drug affinity for the ribosomal target or prevent its access. Resistance arises primarily from 23 S rRNA methylation—a modification of the binding site—or the action of efflux pumps that actively expel the drug from the bacterial cell. These structural and functional overrides prevent Clarithromycin from reaching inhibitory concentrations at the 50 S subunit, which results in the continuation of bacterial replication.

How to Use Kwangdong Clarithromycin

Clarithromycin is administered primarily through the oral route, utilizing immediate-release tablets, extended-release tablets, or an oral suspension. The intravenous (IV) route is an approved alternative, typically restricted to the initial phase of therapy in severe cases before transitioning to oral administration.

Feature	Official Usage Guideline
Standard Adult Dose	250 mg to 500 mg twice daily (every 12 hours) for immediate-release forms, or 1000 mg once daily for extended-release forms.
Administration Timing	Immediate-release forms and the oral suspension may be taken with or without food; however, the extended-release tablets must be taken with food to ensure correct absorption.
Duration of Use	A typical treatment course lasts 6 to 14 days, though duration varies by indication and may be prolonged for opportunistic mycobacterial infections.
Renal Adjustment	For patients with severe renal impairment (creatinine clearance less than 30 mL/min), the total daily dosage must be reduced by one-half.

Procedural Constraints

The granules for oral suspension require reconstitution with water and must be shaken prior to each dose. Furthermore, extended-release tablets must be swallowed whole and not crushed, broken, or chewed, as this action can disrupt the medicine's designed release kinetics. In pediatric patients under 12 years of age, the tablets are not used; a weight-based dose of the oral suspension is administered, typically 7.5 mg/kg twice daily. If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped.

Kwangdong Clarithromycin: Recent Clinical Evidence

Clarithromycin is a macrolide-class antibiotic investigated for use against various bacterial infections. Recent research focuses on its role in respiratory illness and combination therapies, while also highlighting the importance of long-term safety data.

---

Studies in Respiratory Tract Infections

Clinical trials have examined the effect of clarithromycin, often in extended-release formulations, in patients with upper respiratory tract infections (URTIs), including acute otitis media, pharyngotonsillitis, and bacterial sinusitis. These studies evaluated the reported clinical response (such as reduction in symptoms) after a typical course of treatment. The compound has also been studied in community-acquired pneumonia (CAP).

Combination Therapy for H. pylori

Clarithromycin is a component of several combination regimens studied for the eradication of Helicobacter pylori, a bacterium associated with peptic ulcers. Standard first-line treatments often combine clarithromycin with a proton pump inhibitor and another antibiotic, such as amoxicillin. Eradication success rates are highly dependent on local resistance patterns, and international guidelines suggest that clarithromycin-based regimens may be avoided in areas where resistance rates exceed 15–20%.

Important Safety Considerations in Research

Clinical data, including findings from the prospective CLARICOR trial, have been reviewed by regulatory bodies concerning a potential association between short-term clarithromycin use and an increased long-term risk of adverse cardiac outcomes in patients with pre-existing heart disease. Based on this evidence, healthcare professionals are advised to carefully weigh the benefits and potential risks before prescribing clarithromycin to individuals with known heart conditions.

Common questions about Kwangdong Clarithromycin (FAQ)

Q: What happens if I stop taking Kwangdong Clarithromycin too early?

Regulatory guidance and official patient information indicate that stopping any antibiotic prematurely may allow some of the bacteria causing the infection to survive and multiply. This can potentially lead to the infection returning and may contribute to the risk of drug resistance. Completing the full prescribed course is generally described as important.

Q: Why is it important to complete the full prescribed course of treatment?

Completing the full course of treatment as prescribed is intended to help ensure the bacteria causing the infection are neutralized. This process is generally understood to help reduce the risk of the infection recurring or contributing to the development of drug-resistant bacteria.

Q: Is it possible to be allergic to Kwangdong Clarithromycin?

Yes, official regulatory documents state that Kwangdong Clarithromycin is strictly contraindicated for individuals who have a known hypersensitivity, or allergy, to clarithromycin or any other medicine belonging to the macrolide class of antibiotics.

Q: Can Kwangdong Clarithromycin interact with alcohol?

Regulatory sources generally do not list a formal, direct interaction between clarithromycin and alcohol. General patient information notes that limiting alcohol while taking antibiotics is a common practice to support recovery from infection.

Q: What does 'contraindication' mean in the context of Kwangdong Clarithromycin?

A contraindication is a circumstance or condition that officially makes a particular treatment or procedure inadvisable because of the potential for harm. When Kwangdong Clarithromycin is contraindicated, it means the medicine must not be used because the risks outweigh the potential benefits for the person.

Q: Is Kwangdong Clarithromycin linked to heart rhythm issues?

Official safety documents include warnings about the risk of serious cardiac issues, specifically mentioning QT interval prolongation and ventricular tachycardia. These are types of heart rhythm disturbances. Official documentation advises healthcare professionals to exercise caution when prescribing this medicine to individuals with pre-existing heart conditions.

Q: Does Kwangdong Clarithromycin affect the balance of bacteria in the gut?

Yes, as an antibiotic, Kwangdong Clarithromycin can affect the natural balance of beneficial bacteria in the gut. This change can lead to common gastrointestinal side effects such as diarrhea, and, in rare cases, a more serious overgrowth of a harmful bacterium called Clostridioides difficile.

Q: What are the signs of a serious skin reaction mentioned in official warnings?

Official warnings document serious cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome. The general signs of these reactions can include the onset of a rash, blistering, or peeling of the skin, often accompanied by a fever. These reactions are described as requiring immediate attention.

Q: Can Kwangdong Clarithromycin cause dizziness?

Yes, dizziness is listed in the official safety profile as a possible adverse reaction associated with clarithromycin.

Q: Can Kwangdong Clarithromycin cause changes in blood sugar levels?

The official safety documentation lists hypoglycemia (low blood sugar) as a reported adverse reaction for clarithromycin, indicating a potential effect on blood sugar levels.

Q: Why does Kwangdong Clarithromycin sometimes have a bitter taste?

Official regulatory clinical trial data reports dysgeusia (changed or bitter taste) as a frequent adverse reaction. This is thought to occur because the active ingredient, clarithromycin, can be secreted into the oral cavity shortly after administration.

Q: How long does it take for Kwangdong Clarithromycin to start working?

While the time it takes for the drug to reach the infection site is not precisely stated, authorized patient information generally suggests that for most infections, a patient may expect to begin feeling better within a few days of starting the medicine. Improvement time may vary depending on the infection.

Q: What should I do if I forget to take a tablet?

Official guidance states that if a dose is missed, it should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose. If it is nearly time, the missed dose should be skipped entirely. The established regular dosing schedule is then followed.

Q: How long do the side effects of Kwangdong Clarithromycin usually last?

For common, non-serious side effects like nausea or taste disturbance, patient counseling information suggests these effects are temporary. They will typically subside or disappear completely soon after the medicine course has been finished.

Q: Can Kwangdong Clarithromycin affect sleep?

Yes, official safety documents list insomnia (difficulty falling asleep or staying asleep) as a commonly documented side effect associated with clarithromycin.

Q: How is Kwangdong Clarithromycin absorbed by the body?

Clarithromycin is described in official documents as being rapidly absorbed from the gut after it is taken by mouth. Pharmacokinetic data indicates that approximately 50% of the dose is available for the body to use, which is referred to as its absolute bioavailability.

Q: Does Kwangdong Clarithromycin appear in breast milk?

Regulatory documents confirm that clarithromycin has been found in human milk. They state that use is generally not recommended in nursing women unless a healthcare professional has determined that the benefits outweigh the potential risks, and that caution should be exercised.

Q: What is the difference between immediate-release and extended-release forms of clarithromycin?

The extended-release form is designed to release the medication slowly, providing extended absorption to maintain drug levels over a 24-hour period for a once-daily regimen. The immediate-release form releases the medicine quickly, requiring it to be taken twice daily.

Q: Is Kwangdong Clarithromycin used for ear infections?

Yes, clarithromycin is officially indicated for the treatment of various bacterial infections, including acute otitis media (middle ear infections) in patients who are susceptible to the drug.

Q: Does Kwangdong Clarithromycin interact with grapefruit juice?

Official warnings advise caution regarding grapefruit juice and grapefruit products due to the potential for changes in how the medicine is processed by the body. Grapefruit can affect certain enzymes responsible for drug metabolism.

Q: What is the general expectation for improvement time after starting the medicine?

Authorized patient information generally states that a patient may expect to begin feeling better within a few days of starting the medication. The timeframe for full symptom resolution can vary depending on the specific type and severity of the infection being treated.

Q: Does the medicine come in a liquid suspension for those who cannot swallow tablets?

Yes, in addition to tablets, the active ingredient clarithromycin is available as granules for oral suspension. This liquid form is often used for children, but it may also be an option for adult patients who have difficulty swallowing tablets.

Q: Is Kwangdong Clarithromycin used in combination therapies?

Yes, clarithromycin is formally indicated for use as a component in combination regimens for specific medical conditions. This includes its use in regimens to eradicate Helicobacter pylori (a bacterium associated with stomach ulcers) and for the treatment or prevention of Mycobacterium avium disease (MAC).

Q: Does Kwangdong Clarithromycin change the effectiveness of drugs used to treat gout?

Yes, regulatory warnings state that clarithromycin is strictly contraindicated for use with the gout medicine colchicine in patients who also have kidney or liver impairment. This prohibition is due to a severe risk of colchicine toxicity resulting from the interaction.

How to Store and Dispose of Kwangdong Clarithromycin

Official regulatory labeling dictates strict storage and disposal requirements for Kwangdong Clarithromycin tablets.

Storage Conditions

Clarithromycin must be stored at Controlled Room Temperature, which is between 20 C and 25 C (68°F and 77°F). It must be protected from excess heat, moisture, and light, and it is explicitly required to keep the tablets from freezing. The medication must be kept in its original container, tightly closed, and stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired tablets should be disposed of safely. Patients must ask a pharmacist or healthcare professional how to discard the medicine, often utilizing a formal drug take-back program or adhering to specific local waste regulations. The medicine should not be discarded into wastewater or household trash.